Kannel W B
Am J Med. 1983 Sep 26;75(3A):4-11. doi: 10.1016/0002-9343(83)90111-0.
Left ventricular hypertrophy, particularly on the electrocardiogram, is an ominous, not an incidental accompaniment of hypertension and cardiovascular disease. The prevalence of electrocardiographic left ventricular hypertrophy increases with age with a slight male predominance, and one in 10 persons aged 30 to 62 can expect to have it within 12 years. At any age, cardiac enlargement on roentgenograms is twice as prevalent as electrocardiographic left ventricular hypertrophy, and in only 16 percent of those with x-ray evidence of cardiac enlargement does electrocardiographic left ventricular hypertrophy subsequently develop. Hypertension predisposes and at systolic pressures exceeding 180 mm Hg evidence of electrocardiographic left ventricular hypertrophy develops in 50 percent, with no closer relation to diastolic, than to systolic pressure. In addition to drastic curtailment of life expectancy, electrocardiographic left ventricular hypertrophy is a harbinger of serious cardiovascular disease. Definite electrocardiographic left ventricular hypertrophy is associated with an eightfold increase in cardiovascular mortality and a sixfold increase in coronary mortality. Electrocardiographic left ventricular hypertrophy with repolarization criteria more than doubles the risk of hypertension alone and carries a greater risk of cardiovascular morbidity and mortality than cardiac enlargement. It identifies hypertensive patients with a compromised coronary circulation and myocardial damage. Risk of stroke, cardiac failure, and every clinical manifestation of coronary heart disease is substantially increased. In those with electrocardiographic left ventricular hypertrophy risk of cardiac failure is three times that in those with hypertension alone. Electrocardiographic left ventricular hypertrophy based solely on voltage criteria reflects chiefly the severity and duration of associated hypertension, carrying only half the cardiovascular risk of electrocardiographic left ventricular hypertrophy with repolarization abnormality. The precise pathologic and anatomic meaning of electrocardiographic left ventricular hypertrophy is unclear in view of the modest correlations with anatomic, x-ray, ventriculographic, and electrocardiographic measures of cardiac hypertrophy. The electrocardiographic aberrations are as much a product of myocardial damage as hypertrophy, and their appearance must be regarded as a grave prognostic sign in the course of cardiovascular disease.
左心室肥厚,尤其是心电图显示的左心室肥厚,是高血压和心血管疾病的一个不祥而非偶然的伴随症状。心电图左心室肥厚的患病率随年龄增长而增加,男性略占优势,30至62岁的人群中,每10人中有1人预计在12年内会出现这种情况。在任何年龄,X线胸片显示的心脏增大的患病率是心电图左心室肥厚的两倍,在X线有心脏增大证据的患者中,只有16%随后会出现心电图左心室肥厚。高血压是一个诱因,收缩压超过180 mmHg时,50%的患者会出现心电图左心室肥厚的证据,与舒张压相比,与收缩压的关系更为密切。除了大幅缩短预期寿命外,心电图左心室肥厚还是严重心血管疾病的先兆。明确的心电图左心室肥厚与心血管死亡率增加8倍和冠状动脉死亡率增加6倍相关。伴有复极标准的心电图左心室肥厚使单纯高血压的风险增加一倍以上,并且比心脏增大带来更大的心血管发病和死亡风险。它可识别冠状动脉循环受损和心肌损伤的高血压患者。中风、心力衰竭以及冠心病的各种临床表现的风险会大幅增加。在患有心电图左心室肥厚的患者中,心力衰竭的风险是单纯高血压患者的三倍。仅基于电压标准的心电图左心室肥厚主要反映了相关高血压的严重程度和持续时间,其心血管风险仅为伴有复极异常的心电图左心室肥厚的一半。鉴于与心脏肥厚的解剖学、X线、心室造影和心电图测量结果的相关性不大,心电图左心室肥厚的确切病理和解剖学意义尚不清楚。心电图异常既是心肌肥厚的产物,也是心肌损伤的产物,其出现必须被视为心血管疾病病程中的一个严重预后标志。